MaaT Pharma SA (EPA:MAAT)
France · Delayed Price · Currency is EUR 1.062
-0.034 (-3.10%)
Oct 22, 2026, 5:35 PM CEST
MaaT Pharma Market Cap
MaaT Pharma has a market cap or net worth of €20.01 million as of October 22, 2026. It is the 36,059th most valuable company in the world and the 451st biggest in France. Its market cap has decreased by 71.10% in one year.
Market Cap
20.01M
Enterprise Value
26.69M
Revenue
3.18M
Global Rank
Country Rank
#451 France
PE Ratio
n/a
ChartMarket Cap Chart
Since November 8, 2021, MaaT Pharma's market cap has decreased from 132.73M to 20.01M, a decrease of -84.92%. That is a compound annual growth rate of -31.73%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 20.01M | -74.17% |
| Dec 31, 2025 | 77.47M | -29.96% |
| Dec 31, 2024 | 110.61M | 36.57% |
| Dec 29, 2023 | 80.99M | 2.32% |
| Dec 30, 2022 | 79.15M | -40.01% |
| Dec 31, 2021 | 131.95M | -0.59% |
| Nov 8, 2021 | 132.73M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| THX Pharma Société Anonyme | 46.54M |
| Fermentalg | 35.45M |
| Nicox | 25.78M |
| genOway Société anonyme | 20.28M |
| GenSight Biologics | 17.21M |
| Biophytis | 11.13M |
| TME Pharma | 10.39M |
| Poxel | 10.02M |